nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.0553	0.0656	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.0269	0.0318	CcSEcCtD
Betahistine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.023	0.0272	CcSEcCtD
Betahistine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.0219	0.0259	CcSEcCtD
Betahistine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0196	0.0233	CcSEcCtD
Betahistine—Malaise—Spironolactone—dilated cardiomyopathy	0.0191	0.0226	CcSEcCtD
Betahistine—Discomfort—Spironolactone—dilated cardiomyopathy	0.0178	0.0211	CcSEcCtD
Betahistine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.0175	0.0207	CcSEcCtD
Betahistine—Confusional state—Spironolactone—dilated cardiomyopathy	0.0174	0.0206	CcSEcCtD
Betahistine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0173	0.0205	CcSEcCtD
Betahistine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.0166	0.0197	CcSEcCtD
Betahistine—Somnolence—Spironolactone—dilated cardiomyopathy	0.0154	0.0182	CcSEcCtD
Betahistine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.0149	0.0177	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.0146	0.0173	CcSEcCtD
Betahistine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0142	0.0169	CcSEcCtD
Betahistine—Urticaria—Spironolactone—dilated cardiomyopathy	0.0137	0.0163	CcSEcCtD
Betahistine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.0131	0.0155	CcSEcCtD
Betahistine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0127	0.0151	CcSEcCtD
Betahistine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.0125	0.0148	CcSEcCtD
Betahistine—Asthma—Lisinopril—dilated cardiomyopathy	0.0124	0.0147	CcSEcCtD
Betahistine—Pruritus—Spironolactone—dilated cardiomyopathy	0.0122	0.0145	CcSEcCtD
Betahistine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.0122	0.0145	CcSEcCtD
Betahistine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.012	0.0142	CcSEcCtD
Betahistine—HRH3—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0119	0.0761	CbGpPWpGaD
Betahistine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0118	0.014	CcSEcCtD
Betahistine—Dizziness—Spironolactone—dilated cardiomyopathy	0.0114	0.0135	CcSEcCtD
Betahistine—Flatulence—Furosemide—dilated cardiomyopathy	0.0113	0.0134	CcSEcCtD
Betahistine—Vomiting—Spironolactone—dilated cardiomyopathy	0.011	0.013	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.011	0.013	CcSEcCtD
Betahistine—Rash—Spironolactone—dilated cardiomyopathy	0.0109	0.0129	CcSEcCtD
Betahistine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0109	0.0129	CcSEcCtD
Betahistine—Headache—Spironolactone—dilated cardiomyopathy	0.0108	0.0128	CcSEcCtD
Betahistine—Nausea—Spironolactone—dilated cardiomyopathy	0.0103	0.0122	CcSEcCtD
Betahistine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00988	0.0117	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00974	0.0115	CcSEcCtD
Betahistine—HRH3—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00962	0.0617	CbGpPWpGaD
Betahistine—Confusional state—Furosemide—dilated cardiomyopathy	0.00948	0.0112	CcSEcCtD
Betahistine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.0094	0.0111	CcSEcCtD
Betahistine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00939	0.0111	CcSEcCtD
Betahistine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00922	0.0109	CcSEcCtD
Betahistine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00913	0.0108	CcSEcCtD
Betahistine—HRH3—Monoamine Transport—AGT—dilated cardiomyopathy	0.0087	0.0558	CbGpPWpGaD
Betahistine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00852	0.0101	CcSEcCtD
Betahistine—Somnolence—Furosemide—dilated cardiomyopathy	0.00836	0.0099	CcSEcCtD
Betahistine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00812	0.00962	CcSEcCtD
Betahistine—Fatigue—Furosemide—dilated cardiomyopathy	0.0081	0.0096	CcSEcCtD
Betahistine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00802	0.0095	CcSEcCtD
Betahistine—Angioedema—Lisinopril—dilated cardiomyopathy	0.0079	0.00936	CcSEcCtD
Betahistine—Malaise—Lisinopril—dilated cardiomyopathy	0.00779	0.00923	CcSEcCtD
Betahistine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00775	0.00918	CcSEcCtD
Betahistine—Urticaria—Furosemide—dilated cardiomyopathy	0.00747	0.00885	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00731	0.00866	CcSEcCtD
Betahistine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00727	0.00861	CcSEcCtD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00721	0.0462	CbGpPWpGaD
Betahistine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00711	0.00843	CcSEcCtD
Betahistine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00705	0.00836	CcSEcCtD
Betahistine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00693	0.00821	CcSEcCtD
Betahistine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00688	0.00816	CcSEcCtD
Betahistine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00685	0.00812	CcSEcCtD
Betahistine—Asthenia—Furosemide—dilated cardiomyopathy	0.00674	0.00799	CcSEcCtD
Betahistine—Pruritus—Furosemide—dilated cardiomyopathy	0.00665	0.00788	CcSEcCtD
Betahistine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00643	0.00762	CcSEcCtD
Betahistine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00629	0.00745	CcSEcCtD
Betahistine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00627	0.00743	CcSEcCtD
Betahistine—Dizziness—Furosemide—dilated cardiomyopathy	0.00622	0.00737	CcSEcCtD
Betahistine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00621	0.00736	CcSEcCtD
Betahistine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00609	0.00722	CcSEcCtD
Betahistine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00608	0.00721	CcSEcCtD
Betahistine—Vomiting—Furosemide—dilated cardiomyopathy	0.00598	0.00708	CcSEcCtD
Betahistine—Rash—Furosemide—dilated cardiomyopathy	0.00593	0.00702	CcSEcCtD
Betahistine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00592	0.00702	CcSEcCtD
Betahistine—Headache—Furosemide—dilated cardiomyopathy	0.00589	0.00698	CcSEcCtD
Betahistine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00581	0.00689	CcSEcCtD
Betahistine—Urticaria—Lisinopril—dilated cardiomyopathy	0.0056	0.00664	CcSEcCtD
Betahistine—Nausea—Furosemide—dilated cardiomyopathy	0.00558	0.00662	CcSEcCtD
Betahistine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.0052	0.00616	CcSEcCtD
Betahistine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00506	0.006	CcSEcCtD
Betahistine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00499	0.00591	CcSEcCtD
Betahistine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00483	0.00572	CcSEcCtD
Betahistine—HRH1—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00467	0.0299	CbGpPWpGaD
Betahistine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00466	0.00553	CcSEcCtD
Betahistine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00448	0.00531	CcSEcCtD
Betahistine—Rash—Lisinopril—dilated cardiomyopathy	0.00445	0.00527	CcSEcCtD
Betahistine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00444	0.00526	CcSEcCtD
Betahistine—Headache—Lisinopril—dilated cardiomyopathy	0.00442	0.00524	CcSEcCtD
Betahistine—Nausea—Lisinopril—dilated cardiomyopathy	0.00419	0.00496	CcSEcCtD
Betahistine—HRH3—Monoamine Transport—TNF—dilated cardiomyopathy	0.00395	0.0253	CbGpPWpGaD
Betahistine—HRH1—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00392	0.0251	CbGpPWpGaD
Betahistine—HRH1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00378	0.0242	CbGpPWpGaD
Betahistine—HRH3—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00326	0.0209	CbGpPWpGaD
Betahistine—HRH3—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00326	0.0209	CbGpPWpGaD
Betahistine—HRH1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00318	0.0204	CbGpPWpGaD
Betahistine—HRH3—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00303	0.0194	CbGpPWpGaD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00303	0.0194	CbGpPWpGaD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00282	0.018	CbGpPWpGaD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00273	0.0175	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0026	0.0166	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0026	0.0166	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00241	0.0155	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00238	0.0153	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00234	0.015	CbGpPWpGaD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00233	0.0149	CbGpPWpGaD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00221	0.0142	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—RPS6KB1—dilated cardiomyopathy	0.00219	0.014	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.002	0.0128	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00198	0.0127	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00198	0.0127	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00189	0.0121	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00184	0.0118	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00178	0.0114	CbGpPWpGaD
Betahistine—HRH3—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00177	0.0113	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00152	0.00974	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00144	0.00924	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.0014	0.009	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00112	0.00716	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00112	0.00716	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00107	0.00685	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00104	0.00665	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00101	0.0065	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00101	0.0065	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00101	0.00644	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.001	0.00641	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000995	0.00638	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000943	0.00604	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00093	0.00596	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000913	0.00585	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000901	0.00577	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00089	0.0057	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000859	0.0055	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000857	0.00549	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000857	0.00549	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000815	0.00522	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000797	0.00511	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00078	0.005	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000772	0.00495	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000769	0.00493	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00074	0.00474	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00073	0.00468	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.0007	0.00449	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000675	0.00432	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000659	0.00422	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000653	0.00418	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000653	0.00418	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000632	0.00405	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000626	0.00401	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000625	0.00401	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000607	0.00389	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000604	0.00387	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000599	0.00384	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000599	0.00384	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000588	0.00377	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000574	0.00368	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000557	0.00357	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000549	0.00352	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000539	0.00346	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000502	0.00322	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000476	0.00305	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000464	0.00297	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000461	0.00295	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000437	0.0028	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000435	0.00279	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000381	0.00244	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000376	0.00241	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000369	0.00236	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000369	0.00236	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000353	0.00226	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000343	0.0022	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000339	0.00217	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000335	0.00215	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000335	0.00215	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000332	0.00213	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000324	0.00208	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000311	0.002	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000302	0.00193	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000298	0.00191	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000284	0.00182	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000269	0.00172	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000261	0.00167	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000258	0.00165	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000244	0.00157	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000225	0.00144	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000223	0.00143	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000209	0.00134	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.0002	0.00128	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000198	0.00127	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000198	0.00127	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00019	0.00122	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000184	0.00118	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000181	0.00116	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000178	0.00114	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000154	0.000989	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000152	0.000975	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000144	0.000925	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000126	0.000806	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000124	0.000795	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000112	0.000718	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000107	0.000686	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.63e-05	0.000553	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.43e-05	0.000476	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.1e-05	0.000327	CbGpPWpGaD
